FDA approves updated Covid-19 vaccines for dominant XFG variant

Decision allows manufacturers to begin shipping doses, but confusion remains about insurance coverage

The US Food and Drug Administration approved updated Covid-19 vaccines on Thursday, allowing manufacturers to begin shipping doses to pharmacies and doctors’ offices across the country.

The FDA approved Moderna, Novavax-Sanofi and Pfizer-BioNTech’s updated Covid vaccines, the companies ⁠said on Thursday, ⁠after ​an advisory panel recommended that the shots should target ⁠the dominant XFG variant.